Back to results
US 2016/0237092 A1Published application
Pharmaceutical compositions comprising perillyl alcohol derivatives
AssigneeNeOnc Technologies, Inc.
InventorsThomas Chen, Daniel Levin, Satish Pupalli
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition is provided which includes perillyl alcohol conjugated with a therapeutic agent and further includes and a hydrolyzable acylated aliphatic tail. A method of using the pharmaceutical composition is also provided for treating a condition or disease of a patient, e.g., cancer.
Claims31
A compound of the Formula I;
- wherein R is selected from the group consisting of a C4 to C28 linear or branched alkyl, linear or branched C4 to C28 alkeneyl and a linear or branched C4 to C28 alkynyl group;
- or a pharmaceutically acceptable salt thereof.
A compound of the Formula III;
- wherein R1 is selected from a C4 to C28 linear or branched alkyl, linear or branched C4 to C28 alkeneyl or a linear or branched C4 to C28 alkynyl group;
- or a pharmaceutically acceptable salt thereof.
A process for making a compound of the Formula I
- comprising the steps of
- a) reacting Temozolamide with oxalyl chloride in a halogenated solvent to give the isocyanate of Temozolamide Formula A
- b) reacting the isocyanate of Temozolamide with perillyl alcohol in a halogenated solvent to afford a compound of Formula B
- c) reacting the compound of Formula B with an acid chloride of the Formula C
- wherein R is selected from the group consisting of a C4 to C28 linear or branched alkyl, linear or branched C4 to C28 alkeneyl containing 1, 2, 3, 4, or 5 double bonds or a linear or branched C4 to C28 alkynyl group;
- containing 1, 2, 3, 4 or 5 triple bonds in the presence of a base in an ethereal solvent to afford a compound of the Formula I.
3 more elements
Dependencies are inferred from the claim text.